Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic

December 22, 2022 updated by: Karen Zaghiyan, Cedars-Sinai Medical Center
The purpose of this clinical study is to evaluate whether remote video/audio postoperative visits (telemedicine visits) affects patient satisfaction compared to in-person visits during the COVID-19 pandemic. If the primary objective of the study is achieved, it would allow better understanding of how telemedicine can be integrated into modern surgical practice to take care of postoperative patients.

Study Overview

Study Type

Interventional

Enrollment (Actual)

58

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90048
        • Cedars Sinai Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 96 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients over 18 years of age inclusive at the time of the study who underwent colorectal surgery and are presenting for their first postoperative visit
  2. Patients with a computer or phone device with video and audio capabilities

Exclusion Criteria:

  1. Children <18 years of age
  2. Patients with mental disability
  3. Patients without a computer or phone device with video and audio capabilities
  4. Patients who require physical intervention during their first postoperative visit (e.g. drain removal, suture removal, staple removal)
  5. Patients who are readmitted to the hospital prior to their first postoperative visit will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group I
Patients who will undergo telemedicine visit approximately 1 week postoperatively, then an in-person clinic visit approximately 4 weeks postoperatively
A postoperative visit with the patient's surgeon conducted remotely via audio/video smartphone app
Other Names:
  • Remote audio/video visit, telehealth visit
Active Comparator: Group II
Patients who will undergo in-person clinic visit approximately 1 week postoperatively, then a telemedicine visit approximately 4 weeks postoperatively
A standard-of-care in-person postoperatively visit with the patient's surgeon

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction
Time Frame: 7 to 14 days postoperatively
Patient satisfaction score measured by electronic survey sent to all participating patients after their first postoperative visit
7 to 14 days postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-reported rating of safety
Time Frame: 7 to 14 days postoperatively
Patient-reported sense of safety score rated from 1 to 5 with higher scores indicating greater sense of safety. This is designed to gauge how safe patients feel visiting the clinic in-person vs. online via telemedicine during the COVID pandemic
7 to 14 days postoperatively
Length of visit
Time Frame: 7 to 14 days postoperatively
Length of postoperative visit
7 to 14 days postoperatively
Patient willingness to recommend provider to peers rated from 1 to 5
Time Frame: 7 to 14 days postoperatively
Patient willingness to recommend provider to peers rated from 1 to 5
7 to 14 days postoperatively
Combined patient satisfaction score from 1st and 2nd postoperative visits
Time Frame: 7 to 31 days postoperatively
Combined patient satisfaction score from 1st and 2nd postoperative visits
7 to 31 days postoperatively
Distance (in kilometers) of patient's primary residence to the clinic location
Time Frame: 7 to 31 days postoperatively
Distance (in kilometers) of patient's primary residence to the clinic location
7 to 31 days postoperatively
60-day rate of hospital readmission
Time Frame: 60 days postoperatively
Incidence of hospital readmission 60 days postoperatively
60 days postoperatively
60-day rate of re-operation
Time Frame: 60 days postoperatively
Incidence of re-operation 60 days postoperatively
60 days postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karen Zaghiyan, MD, Associate Professor of Surgery

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2020

Primary Completion (Actual)

June 30, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

December 2, 2020

First Submitted That Met QC Criteria

December 2, 2020

First Posted (Actual)

December 3, 2020

Study Record Updates

Last Update Posted (Estimate)

December 26, 2022

Last Update Submitted That Met QC Criteria

December 22, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on Telemedicine visit

Subscribe